These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2462876)

  • 1. An analysis of the inhibition of replication of HIV and MuLV by some 3'-blocked pyrimidine analogs.
    Bazin H; Chattopadhyaya J; Datema R; Ericson AC; Gilljam G; Johansson NG; Hansen J; Koshida R; Moelling K; Oberg B
    Biochem Pharmacol; 1989 Jan; 38(1):109-19. PubMed ID: 2462876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparisons of anti-human immunodeficiency virus activities, cellular transport, and plasma and intracellular pharmacokinetics of 3'-fluoro-3'-deoxythymidine and 3'-azido-3'-deoxythymidine.
    Kong XB; Zhu QY; Vidal PM; Watanabe KA; Polsky B; Armstrong D; Ostrander M; Lang SA; Muchmore E; Chou TC
    Antimicrob Agents Chemother; 1992 Apr; 36(4):808-18. PubMed ID: 1503443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, solution conformation and anti-HIV activity of novel 3'-substituted-2',3'-dideoxy-5-hydroxymethyluridines and their 4,5-substituted analogues.
    Poznanski J; Bretner M; Kulikowski T; Balzarini J; Van Aerschot A; De Clercq E
    Antivir Chem Chemother; 2003 May; 14(3):127-38. PubMed ID: 14521329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antiviral activity of several 2,5'-anhydro analogues of 3'-azido-3'-deoxythymidine, 3'-azido-2',3'-dideoxyuridine, 3'-azido-2',3'-dideoxy-5-halouridines, and 3'-deoxythymidine against human immunodeficiency virus and Rauscher-murine leukemia virus.
    Lin TS; Shen ZY; August EM; Brankovan V; Yang H; Ghazzouli I; Prusoff WH
    J Med Chem; 1989 Aug; 32(8):1891-5. PubMed ID: 2754712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and anti-human immunodeficiency virus type 1 (HIV-1) activity of 3-substituted derivatives of 3'-azido-3'-deoxythymidine (AZT), and inhibition of HIV-1 reverse transcriptase by their 5'-triphosphates.
    Kitade Y; Suzuki A; Hirota K; Maki Y; Nakane H; Ono K; Baba M; Shigeta S
    Chem Pharm Bull (Tokyo); 1992 Apr; 40(4):920-4. PubMed ID: 1381996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, in vitro biological stability, and anti-HIV activity of 5-halo-6-alkoxy(or azido)-5,6-dihydro-3'-azido-3'-deoxythymidine diastereomers as potential prodrugs to 3'-azido-3'-deoxythymidine (AZT).
    Kumar R; Wang L; Wiebe LI; Knaus EE
    J Med Chem; 1994 Dec; 37(25):4297-306. PubMed ID: 7996541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New lipophilic alkyl/acyl dinucleoside phosphates as derivatives of 3'-azido-3'-deoxythymidine: inhibition of HIV-1 replication in vitro and antiviral activity against Rauscher leukemia virus infected mice with delayed treatment regimens.
    Schwendener RA; Gowland P; Horber DH; Zahner R; Schertler A; Schott H
    Antiviral Res; 1994 May; 24(1):79-93. PubMed ID: 7944315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic inhibition of human immunodeficiency virus type 1 replication in vitro by two-drug and three-drug combinations of 3'-azido-3'-deoxythymidine, phosphonoformate, and 2',3'-dideoxythymidine.
    Kong XB; Zhu QY; Ruprecht RM; Watanabe KA; Zeidler JM; Gold JW; Polsky B; Armstrong D; Chou TC
    Antimicrob Agents Chemother; 1991 Oct; 35(10):2003-11. PubMed ID: 1722077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and anti-HIV activity of different sugar-modified pyrimidine and purine nucleosides.
    Herdewijn P; Balzarini J; Baba M; Pauwels R; Van Aerschot A; Janssen G; De Clercq E
    J Med Chem; 1988 Oct; 31(10):2040-8. PubMed ID: 3172142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of human immunodeficiency virus type 1 replication by phosphonoformate esters of 3'-azido-3'-deoxythymidine.
    Rosowsky A; Saha J; Fazely F; Koch J; Ruprecht RM
    Biochem Biophys Res Commun; 1990 Oct; 172(1):288-94. PubMed ID: 2222476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antiviral (HIV-1, HBV) activities of 5-halo-6-methoxy(or azido)-5,6-dihydro-3'-fluoro-3'-deoxythymidine diastereomers. Potential prodrugs to 3'-fluoro-3'-deoxythymidine.
    Kumar R; Wang L; Wiebe LI; Knaus EE
    J Med Chem; 1994 Oct; 37(21):3554-60. PubMed ID: 7932583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sanctuary growth of human immunodeficiency virus in the presence of 3'-azido-3'-deoxythymidine.
    Medina DJ; Tung PP; Lerner-Tung MB; Nelson CJ; Mellors JW; Strair RK
    J Virol; 1995 Mar; 69(3):1606-11. PubMed ID: 7853495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and in vitro activity of long-chain 5'-O-[(alkoxycarbonyl)phosphinyl]-3'-azido-3'-deoxythymidines against wild-type and AZT- and foscarnet-resistant strains of HIV-1.
    Rosowsky A; Fu H; Pai N; Mellors J; Richman DD; Hostetler KY
    J Med Chem; 1997 Aug; 40(16):2482-90. PubMed ID: 9258355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of replication and cytopathic effect of human T cell lymphotropic virus type III/lymphadenopathy-associated virus by 3'-azido-3'-deoxythymidine in vitro.
    Nakashima H; Matsui T; Harada S; Kobayashi N; Matsuda A; Ueda T; Yamamoto N
    Antimicrob Agents Chemother; 1986 Dec; 30(6):933-7. PubMed ID: 2434024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human immunodeficiency virus inhibition is prolonged by 3'-azido-3'-deoxythymidine alternating with 2',3'-dideoxycytidine compared with 3'-azido-3'-deoxythymidine alone.
    Spector SA; Ripley D; Hsia K
    Antimicrob Agents Chemother; 1989 Jun; 33(6):920-3. PubMed ID: 2548440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antiviral activity of some 5'-N-phthaloyl-3'-azido-2',3'-dideoxythymidine analogues.
    Balzarini J; De Clercq E; Kaminska B; Orzeszko A
    Antivir Chem Chemother; 2003 May; 14(3):139-44. PubMed ID: 14521330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of in vitro biological properties and mouse toxicities of three thymidine analogs active against human immunodeficiency virus.
    Mansuri MM; Hitchcock MJ; Buroker RA; Bregman CL; Ghazzouli I; Desiderio JV; Starrett JE; Sterzycki RZ; Martin JC
    Antimicrob Agents Chemother; 1990 Apr; 34(4):637-41. PubMed ID: 1693057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-HIV type 1 activity of 3'-fluoro-3'-deoxythymidine for several different multidrug-resistant mutants.
    Kim EY; Vrang L; Oberg B; Merigan TC
    AIDS Res Hum Retroviruses; 2001 Mar; 17(5):401-7. PubMed ID: 11282008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro anti-hepatitis B virus activities of 5"-O-myristoyl analogue derivatives of 3"-fluoro-2",3"-dideoxythymidine (FLT) and 3"-azido-2",3"-dideoxythymidine (AZT).
    Parang K; Wiebe LI; Knaus EE; Huang JS; Tyrrell DL
    J Pharm Pharm Sci; 1998; 1(3):108-14. PubMed ID: 10948398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic combinations and peptides in the inhibition of human immunodeficiency virus.
    Cox S; Koshida R; Harmenberg J; Wahren B
    Adv Enzyme Regul; 1991; 31():85-97. PubMed ID: 1715118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.